Normal neutrophil function in cathepsin G-deficient mice

Blood

Volumn 94, Issue 12, 1999, Pages 4282-4293

  MacIvor, Debra M ^a   Shapiro, Steven D ^a   Pham, Christine T N ^a   Belaaouaj, Abderazzaq ^a   Abraham, Soman N ^a   Ley, Timothy J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZUROCIDIN; BETA 2 MICROGLOBULIN; CATHEPSIN G; COMPLEMENT COMPONENT C5A RECEPTOR; ESTERASE; INTERLEUKIN 8; LEUKOCYTE ELASTASE; MYELOBLASTIN; MYELOPEROXIDASE; THIOGLYCOLIC ACID;

ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; ENZYME DEFICIENCY; ENZYME SPECIFICITY; ESCHERICHIA COLI; GENOTYPE; HUMAN; HUMAN CELL; KLEBSIELLA PNEUMONIAE; NEUTROPHIL; PHAGOCYTOSIS; PRIORITY JOURNAL; PROMYELOCYTE; STAPHYLOCOCCUS AUREUS;

EID: 0032763069     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.12.4282     Document Type: Article

References (82)

1. Bainton DF, Ullyot JL, Farquhar MG: The development of neutrophilic polymorphonuclear leukocytes in the human bone marrow. J Exp Med 134:907, 1971
2. Hanson RK, Connolly NL, Burnett D, Campbell EJ, Senior RM, Ley TJ: Developmental regulation of the human cathespin G gene in myelomonocytic cells. J Biol Chem 265:1524, 1990
3. Heck LW, Rostand KS, Hunter FA, Brown A: Isolation, characterization, and ammo-terminal amino acid sequence analysis of human neutrophil cahtepsin G from normal donors. Anal Biochem 158:217, 1986
4. Salvesen G, Farley D, Shuman J, Przybyla A, Reilly C, Travis J: Molecular cloning of human cathepsin G: Structural similarity to mast cell and cytotoxic T lymphocyte proteinases. Biochemistry 26:2289, 1987
5. 2: A Janus-faced proteinase with two opposite specificities. EMBO J 15:5481, 1996
6. Hohn PA, Popescu NC, Hanson RD, Salvesen G, Ley TJ: Genomic organization and chromosomal localization of the human cathepsin G gene. J Biol Chem 23:13412, 1989
7. Heusel JW, Scarpati EM, Jenkins NA, Gilbert DJ, Copeland NG, Shapiro SD, Ley TJ: Molecular cloning, chromosomal location, and tissue-specific expression of the murine cathepsin G gene. Blood 81:1614, 1993
8. Crosby JL, Bleackley RC, Nadeau JH: A complex of serine protease genes expressed preferentially in cytotoxic T-lymphocytes is closely linked to the T-cell receptor α- and δ-chain genes on mouse chromosome 14. Genomics 6:252, 1990
9. Hanson RD, Hohn PA, Popescu NC, Ley TJ: A cluster of hematopoietic serine protease genes is found on the same chromosomal band as the human α/δ T-cell receptor locus. Proc Natl Acad Sci USA 87:960, 1990
10. Pham CTN, MacIvor DM, Hug BA, Heuse JW, Ley TJ: Long-range disruption of gene expression by a selectable marker cassette. Proc Natl Acad Sci USA 93:13090, 1996
11. Huang R, Blom T, Hellman L: Cloning and structural analysis of mMCP-1, mMCP-4, and mMCP-5, three mouse mast cell-specific serine proteases. Eur J Immunol 21:1611, 1991
12. Caughey GH, Schaumberg TH, Zerweck EH, Butterfield JH, Hanson RD, Silverman GA, Ley TJ: The human mast cell chymase gene (CMA1): Mapping to the cathepsin G/granzyme gene cluster and lineage-restricted expression. Genomics 15:614, 1993
13. Gurish MF, Nadeau JH, Johnson KR, McNeil HP, Grattan KM, Austen KF, Stevens RL: A closely linked complex of mouse mast cell-specific chymase genes on chromosome 14. J Biol Chem 268: 11372, 1993
14. Zimmer M, Medcalf RL, Fink TM, Mattman C, Lichter P, Jenne DE: Three human elastase-like genes coordinately expressed in the myelomonocyte lineage are organized as a single genetic locus on 19pter. Proc Natl Acad Sci USA 89:8215, 1992
15. Grisolano JL, Sclar GM, Ley TJ: Early meyloid-speciric expression of the human cathepsin G gene in transgenic mice. Proc Natl Acad Sci USA 91:8989, 1994
16. Tanaku T, Minematsu Y, Reilly CF, Travis J, Powers JC: Human leukocyte cathepsin G. Subsite mapping with 4-nitroanilides, chemical modification, and effect of possible cofactors. Biochemistry 24:2040, 1985
17. Maison CM, Villiers CL, Colomb MG: Proteolysis of C3 on U937 cell plasma membranes. J Immunol 147:921, 1991
18. Owen CA, Campbell MA, Sannes PL, Boukedes SS, Campbell EJ: A surface-bound elastase and cathepsin G on human neutrophils: A novel, non-oxidative mechanism by which neutrophils focus and preserve catalytic activity of serine proteases. J Cell Biol 131:775, 1995
19. Stockley RA, Shaw J, Afford SC, Morrison HM, Burnett D: Effect of alpha-1-proteinase inhibitor on neutrophil chemotaxis. Am J Respir Cell Mol Biol 2:163, 1990
20. Lomas DA, Stone SR, Llewellyn-Jones C, Keogan M-T, Wang Z, Rubin H, Carrell RW, Stockley RA: The control of neutrophil chemotaxis by inhibitors of cathepsin G and chymotrypsin. J Biol Chem 270:23437, 1995
21. Gramse M, Bingenheimer C, Havemann K: Degradation of human fibrinogen by chymotrypsin-like neutral protease from human granulocytes. Thromb Res 19:210, 1980
22. Turkington PT, Blumsom NL, Elmore DT: The degradation of bovine and human prothrombin by human polymorphonuclear leukocyte cathepsin G. Thromb Res 44:339, 1996
23. Brezniak DV, Brower MS, Witting JI, Walz DA, Fenton II JW: Human alpha- to zeta-thrombin cleavage occurs with neutrophil cathepsin G or chymotrypsin while fibrinogen clotting activity is retained. Biochemistry 29:3536, 1990
24. Turkington PT: Cathepsin G, a regulator of human vitamin K. Dependent clotting factors and inhibitors. Thromb Res 67:147, 1992
25. Anderssen T, Halvorsen H, Bajaj SP, Osterud B: Human leukocyte elastase and cathepsin G inactivate factor VII by limited proteolysis. Thromb Haemost 70:414, 1993
26. Allen DH, Tracy PB: Human coagulation factor V is activated to the functional cofactor by elastase and cathepsin G expressed at the monocyte surface. J Biol Chem 270:1408, 1995
27. Weksler BB, Jaffe EA, Brower MS, Cole OF: Human leukocyte cathepsin G and elastase specifically suppress thrombin-induced prostacyclin production in human endothelial cells. Blood 74:1627, 1989
28. Molino M, Blanchard N, Belmonte E, Tarver AP, Abrams C, Hoxie JA, Cerletti C, Brass LF: Proteolysis of the human platelet and endothelial cell thrombin receptor by neutrophil-derived cathepsin G. J Biol Chem 270:11168, 1995
29. Renesto P, Chignard M: Enhancement of cathepsin G-induced platelet activation by leukocyte elastase: Consequence for the neutrophil-mediated platelet activation. Blood 82:139, 1993
30. Selak MA, Chignard M, Smith JB: Cathepsin G is a strong platelet agonist released by neutrophils. Biochem J 251:293, 1988
31. Selak MA, Smith JB: Cathepsin G binding to human platelets. Am J Physiol 266:39, 1990
32. Ferrer-Lopez P, Renesto P, Schattner M, Bassot S, Laurent P, Chignard M: Activation of human platelets by C5a-stimulated neutrophils: A role for cathepsin G. Am J Physiol 258:C1100, 1990
33. Evangelista V, Rajtar G, de Gaetano G, White JG, Cerletti C: Platelet activation by fMLP-stimulated polymorphonuclear leukocytes: The activity of cathepsin G is not prevented by antiproteinases. Blood 77:2379, 1991
34. Evangelista V, Piccardone P, White JG, de Gaetano G, Cerletti C: Cathepsin G-dependent platelet stimulation by activated polymorphonuclear leukocytes and its inhibition by antiproteinases: Role of P-selectin-mediated cell-cell adhesion. Blood 81:2947, 1993
35. LaRosa CA, Rohrer MJ, Benoit SE, Rodino LJ, Barnard MR, Michelson AD: Human neutrophil cathepsin G is a potent platelet activator. J Vasc Surg 19:306, 1994
36. Cerletti C, Evangelista V, Molino M, de Gaetano G: Platelet activation by polymorphonuclear leukocytes: Role of cathepsin G and P-selectin. Thromb Haemost 74:218, 1995
37. Si-Tahar M, Renesto P, Falet H, Rendu F, Chignard M: The phospholipase C/protein kinase C pathway is involved in cathepsin G-induced human platelet activation. Comparison with thrombin. Biochem J 313:401, 1996
38. Renesto P, Si-Tahar M, Moniatte M, Balloy V, Van Dorsselaer A, Pidard D, Chignard M: Specific inhibition of thrombin-induced cell activation by the neutrophil proteinases elastase, cathepsin G, and proteinase 3: Evidence for distinct cleavage sites within the aminoterminal domain of the thrombin receptor. Blood 89:1944, 1997
39. Odeberg H, Olsson I: Antibacterial activity of cationic proteins from human granulocytes. J Clin Invest 56:1118, 1975
40. Odeberg H, Olsson I: Mechanisms for the microbicidal activity of cationic proteins of human granulocytes. Infect Immunity 14:1269, 1975
41. Shafer WM, Onunka VC, Martin LE: Antigonococcal activity of human neutrophil cathepsin G. Infect Immunity 54:184, 1986
42. Shafer WM, Onunka VC: Mechanism of staphylococcal resistance to non-oxidative antimicrobial action of neutrophils: Importance of pH and ionic strength in determining the bacterial action of cathepsin G. J Gen Microbiol 135:825, 1989
43. Alford CE, Amaral E, Campbell PA: Listericidal activity of human neutrophil cathepsin G. J Gen Microbiol 136:997, 1990
44. Guyonnet V, Johnson JK, Bangalore N, Travis J, Long PL: In vitro activity of the human neutrophil cathepsin G on Eimeria tenella sporozoites. J Parasitol 77:775, 1991
45. Miyasaki KT, Bodeau AL: In vitro killing of oral Capnocytophaga by granule fractions of human neutrophils is associated with cathepsin G activity. J Clin Invest 87:1585, 1991
46. Bangalore N, Travis J, Onunka VC, Pohl J, Shafer WM: Identification of the primary antimicrobial domains in human neutrophil cathepsin G. J Biol Chem 265:13584, 1990
47. Shafer WM, Polh J, Onunka VC, Bangalore N, Travis J: Human lysosomal cathepsin G and granzyme B share a functionally conserved broad spectrum antibacterial peptide. J Biol Chem 266:112, 1991
48. Shafer WM, Hubalek F, Huang M, Pohl J: Bactericidal activity of a synthetic peptide (CG 117-136) of human lysosomal cathepsin G is dependent on arginine content. Infect Immunity 64:4842, 1996
49. Reilly CF, Tewksbury DA, Schechter NM, Travis J: Rapid conversion of angiotensin I to angiotensin II by neutrophil and mast cell proteinases. J Biol Chem 257:8619, 1982
50. Nahori M-A, Renesto P, Vargaftig BB, Chignard M: Activation and damage of cultured airway epithelial cells by human elastase and cathepsin G. Eur J Pharmacol 228:213, 1992
51. Sommerhoff CP, Nadel JA, Basbaum CB, Caughey GH: Neutrophil elastase and cathepsin G stimulate secretion from cultured bovine airway gland serous cells. J Clin Invest 85:682, 1990
52. Peterson MW: Neutrophil cathepsin G increases transendothelial albumin flux. J Lab Clin Med 113:297, 1989
53. Franzoso G, Biswas P, Poli G, Carlson LM, Brown KD, Tomita-Yamaguchi M, Fauci AS, Siebenlist UK: A family of serine proteases expressed exclusively in myelo-monocytic cells specifically processes the nuclear factor-Kappa B subunit p65 in vitro and may impair human immunodeficency virus replication in these cells. J Exp Med 180:1445, 1994
54. Scuderi P, Nez PA, Derr ML, Wong BJ, Valdez CM: Cathepsin-G and leukocyte elastase inactivate human tumor necrosis factor and lymphotoxin. Cell Immunol 135:299, 1991
55. Hazuda DM, Strickler J, Kueppers F, Simon PL, Young PR: Processing of precursor interleukin 1 beta and inflammatory disease. J Biol Chem 265:6318, 1990
56. Padrines M, Wolf M, Wab A, Baggiolini M: Interleukin-8 processing by neutrophil elastase, cathepsin G and proteinase-3. FEBS Lett 352:231, 1994
57. Malemud CJ, Janoff A: Identification of neutral proteases in human neutrophil granules that degrade articular cartilage proteoglycan. Arthritis Rheum 18:361, 1975
58. Roughley PJ, Barrett AJ: The degradation of cartilage proteoglycans by tissue proteinases. Proteoglycan structure and its susceptibility to proteolysis. Biochem J 167:629, 1977
59. Starkey PM, Barrett AJ, Burleigh MC: The degradation of articular collagen by neutrophil proteinases. Biochem Biophys Acta 483:386, 1977
60. Wintroub BU, Coblyn JS, Kaempfer CE, Austen KF: Cleavage of fibronectin by the human neutrophil neutral peptide-generating protease. Proc Natl Acad Sci USA 77:5448, 1980
61. Reilly CF, Travis J: The degradation of human lung elastin by neutrophil proteinases. Biochim Biophys Acta 621:147, 1980
62. Vartio T, Seppa H, Vaheri A: Susceptibility of soluble and matrix fibronectins to degradation by tissue proteinases, mast cell chymase and cathepsin G. J Biol Chem 256:471, 1981
63. Vartio T: Characterization of the binding domains in the fragments cleaved by cathepsin G from human plasma fibronectin. Eur J Biochem 123:223, 1982
64. Capodici C, Berg RA: Cathepsin G degrades denatured collagen. Inflammation 13:137, 1989
65. Abbott RE, Corral CJ, MacIvor DM, Lin X, Ley TJ, Mustoe TA: Augmented inflammatory responses and altered wound healing in cathepsin G-deficient mice. Arch Surg 133:1002, 1998
66. Heusel JW, Wesselschmidt R, Shresta S, Russell J, Ley TJ: Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 76:977, 1994
67. Ley TJ, Maloney KA, Gordon JI, Schwartz AL: Globin gene expression in erythroid human fetal liver cells. J Clin Invest 83:1032, 1989
68. Senior R, Campbell EJ: Cathepsin G in human mononuclear phagocytes: Comparisons between monocytes and U937 monocyte-like cells. J Immunol 132:2547, 1984
69. Eklund KK, Ghildyal N, Austen F, Friend DS, Schiller V, Stevens RL: Mouse bone marrow-derived mast cells (mBMMC) obtained in vitro from mice that are mast cell-deficient in vivo expresses the same panel of granule proteases as mBMMC and serosal mast cells from their normal littermates. J Exp Med 180:67, 1994
70. Sugawara T, Miyamoto M, Takayama S, Kato M: Separation of neutrophils from blood in human and laboratory animals and comparison of the chemotaxis. J Pharmacol Toxicol Methods 33:91, 1995
71. + progenitors to peripheral blood. J Exp Med 185:111, 1997
72. Kim C, Epner E, Forrester W, Groudine M: Inactivation of the human beta-globin gene by targeted insertion into the beta-globin locus control region. Genes Dev 6:928, 1992
73. Fiering S, Kim C, Epner E, Groudine M: An "in-out" strategy using gene targeting and FLP recombinase for the functional dissection of complex DNA regulatory elements: Analysis of the beta-globin locus control region. Proc Natl Acad Sci USA 90:8469, 1993
74. Fiering S, Epner E, Robinson K, Zhuang Y, Telling A, Hu M, Martin DIK, Enver T, Ley TJ, Groudine M: Targeted deletion of 5′ HS2 of the murine β-globin LCR reveals that it is not essential for proper regulation of the β-globin locus. Genes Dev 9:2203, 1995
75. Hug BA, Wesselschmidt RL, Fiering S, Bender MA, Epner E, Groudine M, Ley TJ: Analysis of mice containing a targeted deletion of β-globin locus control region 5′ hypersensitive 3. Mol Cell Biol 16:2906, 1996
76. Ghildyal N, Friend DS, Nicodemus CF, Austen KF, Stevens RL: Reversible expression of mouse mast cell protease 2 mRNA and protein in cultured mast cells exposed to IL-10. J Immunol 151:3206, 1993
77. Eklund KK, Ghildyal N, Austen KF, Stevens RL: Induction by IL-9 and suppression by IL-3 and IL-4 of the levels of chromosome 14-derived transcripts that encode late-expressed mouse mast cell proteases. J Immunol 151:4266, 1993
78. Kilpatrick L, Johnson JL, Nickbarg EG, Wang Z, Clifford TF, Banach M, Cooperman BS, Douglas SD, Ruhin H: Inhibition of human neutrophil Superoxide generation by alpha-1-antichymotrypsin. J Immunol 146:2388, 1991
79. Kilpatrick L, McCawley L, Naciappan V, Greer W, Majumdar S, Korchak HM, Douglas SD: Alpha-1-antichymotrypsin inhibits the NADPH oxidase-enzyme complex in phorbol ester-stimulated neutrophil membranes. J Immunol 149:3059, 1992
80. Belaaouaj B, McCarthy R, Baumann M, Gao Z, Ley TJ, Abraham SN, Shapiro SD: Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis. Nat Med 4:615, 1998
81. Owen CA, Campbell EJ: Angiotensin II generation at the cell surface of activated neutrophils: Novel cathepsin G-mediated catalytic activity that is resistant to inhibition. J Immunol 160:1436, 1998
82. Chertov O, Ueda H, Xu LL, Tani K, Murphy WJ, Wang JM, Howard OM, Sayers TJ, Oppenheim JJ: Identification of human neutrophil-derived cathepsin G and azurocidin/CAP37 as chemoattractants for mononuclear cells and neutrophils. J Exp Med 186:739, 1997